Vaginal Yeast Infection Latest Advances

Evaluation of the Hologic Aptima Vaginitis assays for microbiological diagnosis of vaginitis in women with abnormal vaginal discharge attending primary care.

Journal: Journal of medical microbiology

Published: May 19, 2026

Antifungal susceptibility of genital yeast isolates, Auckland, 2016-2025.

Journal: The New Zealand medical journal

Published: May 07, 2026

Anatomopathological uterine findings of Candida albicans infection in a vulvovaginal model.

Journal: Journal of medical microbiology

Published: May 07, 2026

Green spectrofluorimetric determination of Ibrexafungerp using NBD-Cl derivatization.

Journal: Scientific reports

Published: April 28, 2026

Indian Fungal Infection National Declaration (I-Find).

Journal: Indian journal of medical microbiology

Published: April 22, 2026

Evolving Epidemiology and Emerging Antifungal Resistance in Vulvovaginal Candidosis: Evidence from a Five-Year Survey.

Journal: Pathogens (Basel, Switzerland)

Published: April 15, 2026

Can Saccharomyces cerevisiae be used as a therapeutic agent for vulvovaginal candidiasis?

Journal: Expert review of anti-infective therapy

Published: April 14, 2026

Honghe Fujie lotion ameliorates pregnancy-associated vulvovaginal candidiasis in mice by inhibiting the activation of NLRP3 inflammasome.

Journal: Experimental animals

Published: April 12, 2026

Limosilactobacillus fermentum 50 alleviates vulvovaginal Candidiasis via the gut-vagina axis: modulating microbiota, barrier function and inflammation.

Journal: Food & function

Published: April 08, 2026

Epidemiology of vulvovaginal candidiasis in China: a six-year retrospective single-center study from a tertiary obstetrics and gynecology hospital in Shanghai.

Journal: Microbiology spectrum

Published: April 07, 2026

From Identification to Resistance: Contemporary Insights into Candida Species Causing Vaginitis.

Journal: Cureus

Published: April 02, 2026

Retraction notice to "Vaginal suppositories of cumin seeds essential oil for treatment of vaginal candidiasis: Formulation, in vitro, in vivo, and clinical evaluation" [European Journal of Pharmaceutical Sciences 157 (2021)105602].

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: March 29, 2026

Vaginal Yeast Infection Latest Advances

Find the Latest Research About Vaginal Yeast Infection

Evaluation of the Hologic Aptima Vaginitis assays for microbiological diagnosis of vaginitis in women with abnormal vaginal discharge attending primary care.

Evaluation of the Hologic Aptima Vaginitis assays for microbiological diagnosis of vaginitis in women with abnormal vaginal discharge attending primary care.

Antifungal susceptibility of genital yeast isolates, Auckland, 2016-2025.

Antifungal susceptibility of genital yeast isolates, Auckland, 2016-2025.

Anatomopathological uterine findings of Candida albicans infection in a vulvovaginal model.

Anatomopathological uterine findings of Candida albicans infection in a vulvovaginal model.

Green spectrofluorimetric determination of Ibrexafungerp using NBD-Cl derivatization.

Green spectrofluorimetric determination of Ibrexafungerp using NBD-Cl derivatization.

Indian Fungal Infection National Declaration (I-Find).

Indian Fungal Infection National Declaration (I-Find).

Evolving Epidemiology and Emerging Antifungal Resistance in Vulvovaginal Candidosis: Evidence from a Five-Year Survey.

Evolving Epidemiology and Emerging Antifungal Resistance in Vulvovaginal Candidosis: Evidence from a Five-Year Survey.

Can Saccharomyces cerevisiae be used as a therapeutic agent for vulvovaginal candidiasis?

Can Saccharomyces cerevisiae be used as a therapeutic agent for vulvovaginal candidiasis?

Honghe Fujie lotion ameliorates pregnancy-associated vulvovaginal candidiasis in mice by inhibiting the activation of NLRP3 inflammasome.

Honghe Fujie lotion ameliorates pregnancy-associated vulvovaginal candidiasis in mice by inhibiting the activation of NLRP3 inflammasome.

Limosilactobacillus fermentum 50 alleviates vulvovaginal Candidiasis via the gut-vagina axis: modulating microbiota, barrier function and inflammation.

Limosilactobacillus fermentum 50 alleviates vulvovaginal Candidiasis via the gut-vagina axis: modulating microbiota, barrier function and inflammation.

Epidemiology of vulvovaginal candidiasis in China: a six-year retrospective single-center study from a tertiary obstetrics and gynecology hospital in Shanghai.

Epidemiology of vulvovaginal candidiasis in China: a six-year retrospective single-center study from a tertiary obstetrics and gynecology hospital in Shanghai.

From Identification to Resistance: Contemporary Insights into Candida Species Causing Vaginitis.

From Identification to Resistance: Contemporary Insights into Candida Species Causing Vaginitis.

Retraction notice to "Vaginal suppositories of cumin seeds essential oil for treatment of vaginal candidiasis: Formulation, in vitro, in vivo, and clinical evaluation" [European Journal of Pharmaceutical Sciences 157 (2021)105602].

Retraction notice to "Vaginal suppositories of cumin seeds essential oil for treatment of vaginal candidiasis: Formulation, in vitro, in vivo, and clinical evaluation" [European Journal of Pharmaceutical Sciences 157 (2021)105602].